Heather Karner outdoors in a garden

RNA Biology / Cancer Systems

Heather Karner, PhD

Decoding the messages that shape cancer.

I study how RNA-binding proteins control mRNA stability, cancer cell fate, metastasis, and therapy response, with experimental systems designed to reflect the patients most affected by disease.

67

RNA-binding proteins profiled in the eclair CLIP atlas

6

breast cancer models profiled for mRNA stability

3

mouse models used for RBMS3 functional validation

The science behind the program

RNA regulation. Profound consequences.

Conceptual schematic / not experimental data

5′3′RBPRBP

eclair CLIP (ecCLIP)

Where proteins meet RNA.

eclair CLIP maps RNA-binding protein interactions at high resolution. The atlas profiles 67 endogenously tagged proteins in HEK293T cells and supports models of RNA stability and RBP–RNA recognition.

Current Momentum

RNA mechanism. Cancer impact.

The program connects genome-scale RNA measurements, mechanistic validation, and equity-centered model selection into one clear question: how do post-transcriptional networks change cancer outcomes?

New Preprint

eclair CLIP & Pythia on bioRxiv

A high-resolution protein–RNA binding atlas and structure-aware modeling. Co-first author, October 13, 2026. Preprint; not peer reviewed.

Read the preprint

Paper

New paper in Science Advances

RBMS3 as a metastasis suppressor in breast cancer. Co-first author, March 2026.

Read the paper

Position

Research Affiliate

Affiliated with UCSF & Arc Institute; contributing to collaborative RNA biology research.

Status

On the Faculty Market

Seeking tenure-track positions in RNA biology, functional genomics, and cancer biology.

Research Program

From RNA half-lives to metastatic behavior.

My lab will define how RNA regulatory circuits are wired, how they break in cancer, and which nodes are powerful enough to change cell fate.

Map RNA regulation at scale

Measure transcriptome-wide mRNA stability and RBP binding across cancer systems chosen for mechanistic and patient relevance.

Find the regulatory logic

Use interpretable models and CRISPRi to connect RNA sequence, structure, binding, decay, and cancer cell behavior.

Build toward better models of disease

Center genetically and ancestrally diverse breast cancer models so discovery biology is also rigorous translational biology.

The next chapter

A program built for collaborative cancer environments.

My future lab will connect RNA mechanism, functional genomics, and diverse patient-derived cancer models. I am seeking a tenure-track position where collaborative science and thoughtful mentorship can turn fundamental discoveries into a deeper understanding of metastatic disease.